Assyro AI

Orange Book product · Brand (NDA)

ALVESCO

CICLESONIDE

Brand (NDA)NDA 021658RX COVIS

At a glance

Jan 10, 2008

Approved

Brand (NDA)

Application

Not listed

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Jan 10, 2008

    18 yr 9 mo ago

  2. Today

  3. Patent 8371292 expires

    Listed method-of-use patent (U-1355) expiration.

    Feb 01, 2028

    in 1 yr 8 mo

Pharmaceutical detail

Active ingredient

CICLESONIDE

Strength

0.16MG/INH

Dosage form

AEROSOL, METERED

Route

INHALATION

TE code

Not listed

Application

NDA 021658

Product number

003

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8371292Feb 01, 2028in 1 yr 8 mo
U-1355
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.